Skip to content

An Online Self-compassion Intervention for Anxiety and Depression in Fathers of Infants: A Feasibility Study

An Online Self-compassion Intervention for Anxiety and Depression in Fathers of Infants: A Feasibility Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07077759
Enrollment
40
Registered
2025-07-22
Start date
2025-10-01
Completion date
2026-10-31
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Depression (PPD)

Keywords

Paternal perinatal depression, father, self-compassion

Brief summary

To investigate the feasibility, acceptability, and preliminary effectiveness of an online mindfulness and self-compassion intervention for the mental health in fathers experiencing paternal perinatal depression (PPD).

Detailed description

The pilot non-RCT will be assessed using an online survey and semi-structured individual interviews. Preliminary effectiveness measures include self-compassion, emotion regulation, resilience, parenting sense of competence, parental stress, marital satisfaction, insomnia, generalized anxiety, and PPD measured at baseline, immediate post-intervention, and 2-month follow-up. Mixed-effects models will test changes between groups, while directed content analysis will be employed for qualitative data.

Interventions

Participants in the intervention group will receive five consecutive weekly sessions, with each session lasting 2 hours (totaling 10 hours). Each session will include an introduction, guided exercises, group discussions and home practice.

Sponsors

Hong Kong Metropolitan University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Intervention model description

non-RCT with a waiting-list control group

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* aged 18 years or above * the biological father who is expecting or the biological father of infants within 24 months old * experienced mild to moderate anxiety (5 ≤ GAD ≤14) or depression symptoms (5≤ PHQ ≤ 19) * sufficient comprehension of Cantonese * currently live in Hong Kong * able to provide informed consent

Exclusion criteria

* currently experiencing psychosis * having an intellectual disability * experiencing current suicidal ideation * participation in a similar study or received similar services in the past year

Design outcomes

Primary

MeasureTime frameDescription
Paternal perinatal depressionFrom enrollment to the end of treatment at 2 months.Paternal perinatal depression will be measured using the Chinese version of the 9-item Patient Health Questionnaire (PHQ-9). Items are rated on a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day). The total score ranges from 0 to 27, with higher total scores indicating higher levels of depressive symptoms. The scale is reliable in the Chinese population (Cronbach's α = 0.82).
AnxietyFrom enrollment to the end of treatment at 2 months.Anxiety symptoms will be measured using the 7-item Generalized Anxiety Disorder-7 (GAD-7). Items are rated on a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day). The total score ranges from 0 to 21, with higher total scores indicating higher levels of anxiety symptoms.

Secondary

MeasureTime frameDescription
Emotion regulationFrom enrollment to the end of treatment at 2 monthsEmotion regulation will be measured by the 10-item Emotion Regulation Questionnaire (ERQ). It includes two subscales: Cognitive reappraisal and expressive suppression. Items are rated on a 7-point scale (1=Strongly Disagree to 7=Strongly Agree). The total score for cognitive reappraisal ranges from 0 to 42, and the total score for expressive supression ranged from 0 to 28. Higher scores mean more frequent use of that strategy.The Cronbach's alpha was 0.82 and 0.77 for cognitive reappraisal and suppression, respectively.
Self-compassionFrom enrollment to the end of intervention at 2 monthsSelf-compassion will be measured using the 12-item short version of the self-compassion scale (SCS). Items are rated on a 5-point Likert scale ranging from 1 (Almost Never) to 5 (Almost Always). The total score ranged from 12 to 60, with higher score indicating higher level of self-compassion. The scale has demonstrated good internal consistency in Chinese sexual minorities (Cronbach's alpha = 0.87)
ResilienceFrom enrollment to the end of treatment at 2 months.Resilience will be measured by the six-item brief resilience scale (BRS). Items are rated on a five-point Likert scale ranging from 1 (Strongly Disagree) to 5 (Strongly Agree). The total score ranges from 6 to 30, with higher score indicating higher level of resilience.
insomniaFrom enrollment to the end of treatment at 2 months.Insomnia will be measured using the 7-item Insomnia Severity Index (ISI). Items are measured on five point likert scale (0-4). The total score of 0-28, with higher scores meaning worse insomnia.
Parent sense of competencyFrom enrollment to the end of treatment at 2 months.Participant's sense of parent competency will be measured using the 17-item Parent Sense of Competency Scale (PSOC). Items are rated on a 6 point Likert scale anchored by 1 = "Strongly Disagree" and 6 = "Strongly Agree". The total score ranged from 17 to 102, with higher score indicating high level of parent competency.
Parental stressFrom enrollment to the end of treatment at 2 months.Parental stress will be measured using the 17-item of the Chinese version of Parental Stress Scale (PSS). Items are raged on a 6-point Likert scale (1 = strongly disagree, 6 = strongly agree). The total score ranges from 17 to 102, with higher score indicating higher level of parental stress.

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 28, 2026